These data suggest regulatory mechanisms whereby tumors with low miR-203 output, have an increase in EGFR ligands (EREG and TGFA) and anti-apoptotic proteins (API5, BIRC2, and TRIAP1) expression, resulting in prostate cancer bone metastasis and TKIs resistance. Here, API5 is linked to Familial prostate cancer.